Watch out Merck: Heron snagged FDA approval on Emend competitor
San Diego’s Heron Therapeutics $HRTX has won FDA approval for Cinvanti to prevent nausea and vomiting for patients on chemo. The drug will directly compete …
Sign up to read this article for free.
Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.
